Halozyme to Participate in the TD Cowen 45th Annual Healthcare Conference
Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced that Dr. Helen Torley, president and chief executive officer, will present and host investor meetings at the TD Cowen 45th Annual Healthcare Conference.
Septerna to Present at TD Cowen 45th Annual Health Care Conference
About Septerna Septerna, Inc. is a biotechnology company pioneering a new era of GPCR drug discovery powered by its proprietary Native Complex Platform™. Its industrial-scale platform aims to unlock the full potential of GPCR therapies and has led to the discovery and development of its deep pipeline of oral small molecule product candidates focused initially on treating patients in three therapeutic areas: endocrinology,
Global health company The Cigna Group (NYSE:CI) announced today that Brian Evanko, EVP and CFO of The Cigna Group, and ...
In his welcoming remarks, AHA President and CEO Rick Pollack discussed some of the immediate threats to rural hospitals' well ...
The annual LGBTQ+ Health Care Conference, hosted by the IU School of Medicine, was canceled Jan. 29 because of “challenging” ...
Following the shooting at UPMC Memorial Hospital there have been renewed calls to increase security at health care facilities ...
Playbook Conference – Strategies and Solutions for the Future of Healthcare is scheduled for April 2 in Nashville, Tennessee.
The conference aimed to advocate for their better integration into international, regional, and national systems to enhance ...
A webcast of each conference presentation will be available on the “Events & Presentations” page within the Investors section of the Alector website at https://investors.alector.com. Replays of the ...
The annual industry event may be over, but the experiences and announcements shared can have a lasting impact.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback